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http://dx.doi.org/10.1016/j.jmu.2013Many primary hepatic tumors such as the rare pediatric neoplasms can be evaluated by sonog-
raphy. Infantile hepatic hemangioendothelioma (IHH), the most common hepatic benign
vascular tumor in infancy, has an excellent prognosis and spontaneous involution within 6e8
months in most cases. A 25-day-old baby girl was admitted to the hospital due to nonbilious
vomiting for 2 days. Sonography showed multiple hypoechoic masses in the liver, and abdom-
inal computed tomography demonstrated multifocal hypervascular lesions that were charac-
teristic of IHH. The patient was then treated with supportive care and discharged in a
stable condition without medication. Serial follow-up sonographic examinations showed that
the size of the masses decreased gradually. At the age of 11 months, a follow-up sonogram
confirmed complete resolution of IHH. Sonography is a useful and convenient method for diag-
nosis and follow-up of IHH. Long-term follow-up is necessary for IHH, even if the lesions are in
regression, to watch for rare but possible malignant transformation.
ª 2013, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
Open access under CC BY-NC-ND license.Introduction
Primary hepatic tumors are rare in children and account for
about 0.2e5% of pediatric neoplasms [1]. Sonography is a
useful imaging modality to evaluate neonatal liver tumors.g Lin, Ho Meng Che Clinic,
istrict, Taichung City 427,
t.net (C.-H. Lin).
C and the Chinese Taipei Society
.04.003Infantile hepatic hemangioendothelioma (IHH), the most
common hepatic benign vascular tumor in infancy, has an
excellent prognosis and, in most cases, spontaneous invo-
lution within 6e8 months [2,3]. In the past, open liver bi-
opsy and angiography were used most frequently to make
the diagnosis. However, the sonographic feature of this
condition has been described as multiple well-defined
hypoechoic masses, and computed tomography (CT)
demonstrated intense enhancement in these homoge-
neously hypodense masses after intravenous contrast agent
administration. We present a case of IHH in which theof Ultrasound in Medicine. Open access under CC BY-NC-ND license.
108 W.-C. Lin et al.diagnosis was established with the use of noninvasive im-
aging techniques. Serial follow-up sonographic examina-
tions were performed, and tumor regression without any
medication was observed at the age of 11 months.
Case report
A 25-day-old baby girl presented with nonbilious vomiting
for 2 days was transferred to our hospital. The infant was
born at 37 weeks of gestation by normal vaginal delivery.
Neither polyhydramnios nor abdominal mass was mentioned
on prenatal sonographic examination, and there were no
specific findings on the clinical examination at birth. On
admission, her weight was 3.8 kg (25th and 50th percen-
tiles) and length 57 cm (50th percentile). The heart rate
was 130 beats per minute without murmur, and respiratory
rate was 40 breaths per minute. On physical examination,
abdominal distention and hepatomegaly were found 2 cm
below the right costal margin, but there was no abdominal
bruit on auscultation. No lymphadenopathy, splenomegaly,
or cutaneous lesion was noted.
Initial laboratory evaluation showed that hemoglobin,
hematocrit, platelet count, white blood cell count, and
electrolytes were within normal limits. Plain films of the
chest and abdomen revealed no specific findings. Abdom-
inal sonography showed multiple hypoechoic tumors (the
largest one was 3.8 cm in size) in the liver (Fig. 1A). On
Doppler evaluation, blood flow without obvious shunting
was noted within the tumors (Fig. 1B). Non-contrast-
enhanced CT scan of the abdomen revealed diffuse,
multifocal, homogeneous hypodense lesions of varying sizes
in the liver (Fig. 2A); these lesions showed marked
enhancement after the injection of contrast medium on
arterial phase and remained mildly hyperdense in venous
phase (Fig. 2B). Laboratory investigations of liver function
later revealed that serum total bilirubin was 4.4 mg/dL
(normal: <1.1 mg/dL), alanine aminotransferase 20 IU/L
(normal: 5e40 IU/L), aspirate aminotransferase 33 IU/L
(normal: 5e34 IU/L), and alpha-fetoprotein (AFP) 2946 ng/
mL (normal: 30e5800 ng/mL). The multifocal tumors ofFig. 1 (A) Abdominal sonography revealed multiple hypoecho
(B) Blood flow without shunting in the masses was noted on Dopplvascular origin allowed the diagnosis of IHH to be made
without the use of more invasive diagnostic procedures
such as liver biopsy or angiography, which was considered
unsafe due to a high risk of bleeding. Cardiac echogram
showed no high-output congestive heart failure.
The patient was treated with supportive care and dis-
charged in a stable condition without oral medication. The
follow-up AFP level was 234 ng/mL (normal: 27e788 ng/mL)
at the age of 3 months and 23 ng/mL (normal: 6e59 ng/mL)
at the age of 11 months. A series of sonographic follow-up
examinations (performed 1 month and 3 months, 6 months,
and 9 months later) showed a gradual decrease in the size
of the tumor and complete resolution at the age of 11
months (Fig. 3). The patient was completely clinically
asymptomatic during follow-up.
Discussion
IHH, accounting for 2e3% of all pediatric neoplasms, is the
most common vascular hepatic tumor in children [1]. Eight-
five percent of patients are diagnosed within the first 6
months of life, and female-to-male ratio varies from 1.3:1
to 2:1 [1e3]. Previous literature reported that the most
common clinical presentations are asymptomatic hepato-
megaly and abdominal mass (38e83%), followed by cuta-
neous hemangioma (11e66%) [1e3]. Congestive heart
failure with a high cardiac output was observed in up to
50e60% of patients; however, this feature seems relatively
rare (0e30%) in recent studies, especially in oriental
children [3e6]. Our patient had a history of 2 days of
vomiting prior to admission, which was considered due to
overfeeding, excessive air swallowing, or viral acute
gastritis and presumed not related to the hepatic tumor.
The exact presentation of IHH in our patient was abdominal
mass, which was found by a detailed physical examination
after admission.
The initial investigation for diagnosis of IHH is sonogra-
phy, which often shows a single or, more commonly, mul-
tiple iso- or hypoechoic masses in the liver. Although the
lesion is often homogeneous, it may sometimes beic masses (white arrows) throughout the liver parenchyma.
er examination.
Fig. 2 (A) Nonenhanced computed tomography (CT) scan shows multifocal homogenous hypodense hepatic masses (black arrows)
with varying size. (B) Enhanced CT scan shows marked enhancement of the lesions (black arrows).
Spontaneous Regression of IHH 109heterogeneous, making it difficult to differentiate from
hepatoblastoma, mesenchymal hamartoma, or metastatic
neuroblastoma [7]. However, the AFP level is usually
markedly elevated in patients with hepatoblastoma. In IHH,
enlarged hepatic artery and proximal aorta with tapering of
the diameter of distal aorta below the orifice of the celiac
artery, low-resistance flow in the hepatic artery with
arteriovenous shunting, and enlarged hepatic vein due to
marked blood flow through lesions may be detectable on
color Doppler examination; these features cannot be
observed in mesenchymal hamartoma [7,8]. Antenatal
diagnosis of IHH by sonography during routine pregnancy
examination has been reported; however, the prenatal so-
nography in our patient failed to detect the hepatic tumors,
possibly due to their small size. For follow-up examina-
tions, sonography is the first choice because it is simple to
perform, is inexpensive, and involves no radiation expo-
sure. CT is a more accurate technique for diagnosing IHH; it
demonstrates well-defined solitary or multifocal massesFig. 3 Sonography shows a reduction in the size of hemangioendo
months showed that the corresponding hemangioendothelioma has
at 9 months showed that the lesion had reduced in size comparedwith varying size, which are homogeneously hypodense on
nonenhanced image but show intense enhancement after
contrast medium injection [8,9]. Some lesions have central
cleft-like hypodense areas, indicating tumoral necrosis
[10]. In addition, it can definitely exclude the possibility of
metastasis from an intra-abdominal neuroblastoma. On
magnetic resonance imaging (MRI), IHH lesions are hetero-
geneously hypointense on T1-weighted image and hyper-
intense on T2-weighted image, compared to the normal
liver parenchyma [11]. Dynamic gadolinium-enhanced MRI
shows an early, prominent, and nodular peripheral
enhancement, followed by a delayed central enhancement
[12]. Angiography should be reserved for patients with
equivocal CT findings, or when either surgery or therapeu-
tic tumor embolization is being considered [12].
There is no specific laboratory test for the diagnosis of
IHH, but elevated aminotransferase levels were reported in
30e50% of IHH cases [3e6]. AFP, which is usually considered
to be an important tumor marker for hepatoblastoma,thelioma in the liver. (A) Follow-up sonography performed at 6
reduced in size spontaneously. (B) Follow-up sonography taken
to the earlier sonography.
110 W.-C. Lin et al.hepatocellular carcinoma, and germ cell tumors, is rarely
elevated in IHH [5]. However, an increased AFP level of as
high as 80% was reported in the study of Zhang et al [4].
Other hematologic abnormalities, including anemia,
thrombocytopenia, thrombocytosis, hyperbilirubinemia,
and leukocytosis, may also be present [4,5]. The laboratory
evaluation in our patient showed no specific findings except
mild elevation of serum bilirubin, which may be due to
breast feeding.
The gold standard for diagnosis of IHH is histopathological
examination, which reveals small vessels lined by a single
layer of plump endothelial cells contained in a myxomatous
stroma that includes small bile ducts [2,4]. However, liver
biopsies are usually unnecessary to confirm the diagnosis and
may result in significant uncontrollable internal bleeding
[2e4]. Reviewing the literature,most of the diagnoses of IHH
were made by imaging findings, and the tumors were
examined histopathologically only when the diagnosis could
not be established radiologically [5,6]. In our patient, the
diagnosis of IHH was made by clinical magnifications and
imaging studies such as sonography and CT.
Treatment of IHH is not needed in asymptomatic cases;
they can be followed up clinically and sonographically,
without any medication. However, for patients with symp-
toms such as congestive heart failure, anemia, thrombo-
cytopenia, coagulopathy, and deterioration of hepatic
function tests [3,4], treatment with oral corticosteroids,
interferon-alpha, or vincristine is recommended as a first-
line therapy. Surgical resection is recommended for a soli-
tary huge mass with a low potential for spontaneous
regression [3e5]. Embolization has been recently accom-
plished in many studies of multiple unresectable tumors
and used in feeding artery. The use of therapeutic radiation
and cyclophosphamide still remains controversial; however,
the possibility of long-term sequelae of hepatic irradiation
makes radiotherapy an undesirable form of treatment for
children [13].
The prognosis of IHH is excellent, except in patients with
thrombocytopenia, hemolytic anemia, intravascular con-
sumption coagulopathy, and congestive heart failure, which
contribute to the mortality substantially [4]. Pediatricians
should be more alert and pay close attention to these com-
plications, and choose the best treatment strategy. Although
IHH is a benign tumor, the literature reported that two pa-
tients with IHH in infancy developed angiosarcoma 4 years
and 5 years later [13]. In addition, a malignant liver tumor
occurring several years after diagnosis of IHH with good
response to medical treatment has been reported [14].
Therefore, long-term clinical and sonographic follow-ups
should be scheduled in patients with IHH, irrespective of
whether they are asymptomatic patients or tumor resolution
cases. Our patient was asymptomatic; on serial sonographicfollow-up, the number of lesions did not increase and
regression of the largest lesion was visible after 2 months,
with continued shrinkage up to 9 months. Follow-up sonog-
raphy at the age of 11 months confirmed our clinical
impression of resolution of the disease without complica-
tion. The patient is now 1.5 years old and still scheduled for
long-term sonographic follow-up every 6 months.
IHH is the most common hepatic vascular tumor in in-
fancy. Sonography is a useful and convenient method for
diagnosis of IHH, which appears as a hypoechoic liver mass.
Asymptomatic patients can be followed up by serial so-
nography to visualize the anticipated spontaneous regres-
sion. Long-term follow-up is necessary, even if the lesions
are in regression, to watch for rare but possible malignant
transformation.References
[1] Finegold MJ, Egler RA, Goss JA, et al. Liver tumors: pediatric
population. Liver Transpl 2008;14:1545e6.
[2] Emre S, McKenna GJ. Liver tumors in children. Pediatr
Transplant 2004;8:632e8.
[3] Moon SB, Kwon HJ, Park KW, et al. Clinical experience with
infantile hepatic hemangioendothelioma. World J Surg 2009;
33:597e602.
[4] Zhang Z, Chen HJ, Yang WJ, et al. Infantile hepatic heman-
gioendothelioma: a clinicopathologic study in a Chinese pop-
ulation. World J Gastroenterol 2010;16:4549e57.
[5] Kim EH, Koh KN, Park M, et al. Clinical features of infantile
hepatic hemangioendothelioma. Korean J Pediatr 2011;54:
260e6.
[6] Sevinir B, Ozdan TB. Infantile hepatic hemangioendothelioma:
clinical presentation and treatment. Turk J Gastroenterol
2007;18:182e7.
[7] Keslar PJ, Buck JL, Selby DM. From the archives of the AFIP.
Infantile hemangioendothelioma of the liver revisited.
Radiographics 1993;13:657e70.
[8] Diakoumakis EE, Weinberg B, Seife B, et al. Infantile heman-
gioendothelioma of the liver. J Clin Ultrasound 1986;14:137e9.
[9] Chung EM, Cube R, Lewis RB, et al. Pediatric liver masses:
radiologicepathologic correlation part 1. Benign tumors. Ra-
diographics 2010;30:801e26.
[10] Ng WH, Ching ASC, Chan KF, et al. Clinics in diagnostic imag-
ing. Singapore Med J 2003;448:491e5.
[11] Feng ST, Chan T, Ching ASC, et al. CT and MR imaging char-
acteristics of infantile hepatic hemangioendothelioma. Eur J
Radiol 2010;76:e24e9.
[12] Lucaya J, Enriquez G, Amat L, et al. Computed tomography of
infantile hepatic hemangioendothelioma. AJR Am J Roent-
genol 1985;144:821e6.
[13] Weinberg AG, Fiengold MJ. Primary hepatic tumors of child-
hood. Hum Pathol 1983;14:512e37.
[14] Nazir Z, Pervez S. Malignant vascular tumors of liver in neo-
nates. J Pediatr Surg 2006;41:e49e51.
